These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 817293)
1. Development and chimpanzee testing of a vaccine against human hepatitis B. Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR Proc Soc Exp Biol Med; 1976 Apr; 151(4):694-700. PubMed ID: 817293 [TBL] [Abstract][Full Text] [Related]
2. Vaccine against human hepatitis B. Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR JAMA; 1976 Jun; 235(26):2832-4. PubMed ID: 819667 [TBL] [Abstract][Full Text] [Related]
3. Successful postexposure vaccination against hepatitis B in chimpanzees. Iwarson S; Wahl M; Ruttimann E; Snoy P; Seto B; Gerety RJ J Med Virol; 1988 Aug; 25(4):433-9. PubMed ID: 3171558 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles. Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967 [TBL] [Abstract][Full Text] [Related]
5. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge. Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood. Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148 [TBL] [Abstract][Full Text] [Related]
7. Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine. Tabor E; Barker LF; Gerety RJ J Med Virol; 1981; 6(4):279-84. PubMed ID: 7241095 [TBL] [Abstract][Full Text] [Related]
8. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386 [TBL] [Abstract][Full Text] [Related]
10. [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)]. Stamm B; Gerlich W; Thomssen R Med Microbiol Immunol; 1979 May; 167(2):83-97. PubMed ID: 572908 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). Fujisawa Y; Kuroda S; Van Eerd PM; Schellekens H; Kakinuma A Vaccine; 1990 Jun; 8(3):192-8. PubMed ID: 2363298 [TBL] [Abstract][Full Text] [Related]
12. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen. Schellekens H; de Reus A; Peetermans JH; van Eerd PA Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363 [TBL] [Abstract][Full Text] [Related]
13. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Davis HL; McCluskie MJ; Gerin JL; Purcell RH Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7213-8. PubMed ID: 8692971 [TBL] [Abstract][Full Text] [Related]
14. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination. Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117 [TBL] [Abstract][Full Text] [Related]
15. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A Hepatology; 1981; 1(5):377-85. PubMed ID: 7030902 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results. Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039 [TBL] [Abstract][Full Text] [Related]
17. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Purcell RH; Gerin JL Am J Med Sci; 1975; 270(2):395-9. PubMed ID: 828832 [TBL] [Abstract][Full Text] [Related]
19. Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture. McAleer WJ; Markus HZ; Wampler DE; Buynak EB; Miller WJ; Weibel RE; McLean AA; Hilleman MR Proc Soc Exp Biol Med; 1984 Mar; 175(3):314-9. PubMed ID: 6320212 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein. Emini EA; Larson V; Eichberg J; Conard P; Garsky VM; Lee DR; Ellis RW; Miller WJ; Anderson CA; Gerety RJ J Med Virol; 1989 May; 28(1):7-12. PubMed ID: 2723618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]